Advertisement
FREE TO ATTEND !FOOD & REFRESHMENTS PROVIDED
BRING A BUSINESS CARD FOR RAFFLE ENTRY
Davenport Grand Hotel
Meeting Room 10
Parking will be validated!
At DRUGSCAN, we share the commitment to elevate interagency collaboration. In this spirit, we will be discussing recent and relevant data to inform our community about drug trends, specifically the over-prescribing of stimulants, as well as the many issues surrounding Xylazine (availability/prevalence, legislative changes, harm reduction, co-positivity patterns, and utility).
Gina M. Cooper MSN, RN, BA, NE-BC is the Director of Toxicology at Drugscan, Inc. Prior to working at Drugscan, Gina was in nursing leadership at Community Physician Network in Indianapolis, IN, a network of over 200 physicians in more than 80 clinics where she oversaw opioid stewardship and educated providers on prescribing laws and guidelines for controlled substances. Gina was the head of clinical toxicology at the American Institute of Toxicology with expertise in toxicological interpretation and best practice use of toxicology testing for quality clinical outcomes. She is a practicing Registered Nurse with expertise in pain management and substance use disorders. Gina has participated in many harm reduction initiatives including leading over 20 community-based overdose awareness classes with naloxone administration training. She earned her bachelor’s in biology, her bachelor’s in Nursing, holds a Master’s in Nursing and is a Board-Certified Nurse Executive.
Advertisement
Event Venue & Nearby Stays
The Davenport Grand (333 West Spokane Falls Boulevard, Spokane, WA), United States
